Inactive Instrument
Alexion Pharmaceuticals, Inc. Share Price
Stocks
ALXN
US0153511094
Pharmaceuticals
| 1 day | +1.70% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 74 | - |
Sean Christie
DFI | Director of Finance/CFO | 53 | 31/07/2021 |
Doyle Shane
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ruud Dobber
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/07/21 | Issuer sale | Chief Operating Officer | 172,582 | 0.0781% | ||
| 21/07/21 | Issuer sale | Director | 28,216 | 0.0128% | ||
| 21/07/21 | Issuer sale | Chief Financial Officer | 120,253 | 0.0544% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | -2.20% | - | - | 40.34B | |
| -2.54% | +1.75% | +56.75% | +117.82% | 1,165B | |
| -1.42% | +4.16% | +36.73% | +72.42% | 645B | |
| +0.16% | +0.79% | +24.91% | +95.34% | 504B | |
| -0.31% | +2.95% | +39.36% | +63.56% | 380B | |
| -1.34% | +0.06% | +65.81% | +41.49% | 363B | |
| -0.68% | +1.67% | +22.07% | +50.94% | 297B | |
| -1.20% | +0.99% | +2.26% | +22.95% | 269B | |
| -1.79% | +1.20% | +48.41% | +57.55% | 237B | |
| -0.73% | -0.85% | +28.47% | +100.57% | 195B | |
| Average | -0.20% | +2.54% | +36.09% | +69.18% | 450.61B | |
| Weighted average by Cap. | -0.12% | +3.17% | +40.78% | +80.33% |
Employees
3,837
Sector
Pharmaceuticals
